Ocular graft-versus-host disease after allogeneic stem cell transplantation

Cornea

Volumn 29, Issue 7, 2010, Pages 758-763

  Westeneng, Arnaud C ^a   Hettinga, Ymkje ^a   Lokhorst, Henk ^a   Verdonck, Leo ^a   Van Dorp, Suzanne ^a   Rothova, Aniki ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

allogeneic stem cell transplantation; ocular graft versus host disease

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; THYMOCYTE ANTIBODY; VALACICLOVIR; VALGANCICLOVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLEPHARITIS; CATARACT; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONJUNCTIVITIS; CORNEA ULCER; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DAILY LIFE ACTIVITY; DRY EYE; EPSTEIN BARR VIRUS INFECTION; EYE DISEASE; EYE EXAMINATION; EYE INFECTION; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOMA; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; OPHTHALMOLOGY; PAPILLITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINOPATHY; SCHIRMER TEST; SKIN DISEASE; UVEITIS; VASCULAR DISEASE; VISUAL ACUITY; VISUAL IMPAIRMENT; ADOLESCENT; ALLOTRANSPLANTATION; DRY EYE SYNDROMES; EYE DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLEPHARITIS; CONJUNCTIVITIS; DRY EYE SYNDROMES; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PREVALENCE; PROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; UVEITIS; YOUNG ADULT;

EID: 77954423252     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181ca321c     Document Type: Article

References (51)

1. Burroughs L, Storb R. Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease. Curr Opin Hematol. 2005;12:45-54. (Pubitemid 40189239)
2. Cutler C, Giri S, Jeyapalan S, et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol. 2001;19:3685-3691. (Pubitemid 32786281)
3. Grewal SS, Barker JN, Davies SM, et al. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood. 2003;101: 4233-4244. (Pubitemid 36857783)
4. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411:385-389.
5. Jaksch M, Mattsson J. The pathophysiology of acute graft-versus-host disease. Scand J Immunol. 2005;61:398-409. (Pubitemid 40695010)
6. Peggs KS, Mackinnon S. Exploiting graft-versus-tumour responses using donor leukocyte infusions. Best Pract Res Clin Haematol. 2001;14:723-739.
7. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25: 139-170. (Pubitemid 46697905)
8. Dean RM, Bishop MR. Graft-versus-host disease: emerging concepts in prevention and therapy. Curr Hematol Rep. 2003;2:287-294.
9. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956. (Pubitemid 41754712)
10. Lee SJ. New approaches for preventing and treating chronic graft-versus-host disease. Blood. 2005;105:4200-4206.
11. Couriel D, Caldera H, Champlin R, et al. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004; 101:1936-1946. (Pubitemid 39425368)
12. Deeg HJ, Antin JH. The clinical spectrum of acute graft-versus-host disease. Semin Hematol. 2006;43:24-31. (Pubitemid 43063332)
13. Lew J, Smith JA. Mucosal graft-vs-host disease. Oral Dis. 2007;13: 519-529. (Pubitemid 47610631)
14. Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004;15:503-507. (Pubitemid 39564472)
15. Kim SK. Update on ocular graft versus host disease. Curr Opin Ophthalmol. 2006;17:344-348. (Pubitemid 44215042)
16. Sanders JE. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int J Hematol. 2002;76(Suppl 2): 15-28.
17. Bray LC, Carey PJ, Proctor SJ, et al. Ocular complications of bone marrow transplantation. Br J Ophthalmol. 1991;75:611-614.
18. Franklin RM, Kenyon KR, Tutschka PJ, et al. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983;90:4-13.
19. Jack MK, Jack GM, Sale GE, et al. Ocular manifestations of graft-v-host disease. Arch Ophthalmol. 1983;101:1080-1084.
20. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea. 2003;22:S19-S27. (Pubitemid 37169601)
21. Saito T, Shinagawa K, Takenaka K, et al. Ocular manifestation of acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. Int J Hematol. 2002;75:332-334. (Pubitemid 43014070)
22. Chakrabarti S, Collingham KE, Osman H, et al. Cidofovir as primary preemptive therapy for post-transplant cytomegalovirus infections. Bone Marrow Transplant. 2001;28:879-881. (Pubitemid 33107616)
23. Chiang CC, Lin JM, Chen WL, et al. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea. 2007;26:861-863. (Pubitemid 47220561)
24. Dai E, Couriel D, Kim SK. Bilateral marginal keratitis associated with engraftment syndrome after hematopoietic stem cell transplantation. Cornea. 2007;26:756-758. (Pubitemid 47080302)
25. Hettinga YM, Verdonck LF, Fijnheer R, et al. Anterior uveitis: a manifestation of graft-versus-host disease. Ophthalmology. 2007;114: 794-797. (Pubitemid 46483677)
26. Kawano N, Gondo H, Kamimura T, et al. Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. Int J Hematol. 2003;78:370-373. (Pubitemid 37532395)
27. Miyamoto T, Gondo H, Miyoshi Y, et al. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol. 1998;100: 348-350. (Pubitemid 28131069)
28. Ogawa Y, Okamoto S, Kuwana M, et al. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Cornea. 2001;20:430-434. (Pubitemid 32381828)
29. Rocha EM, Pelegrino FS, de Paiva CS, et al. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant. 2000;25:1101-1103.
30. Stark D, Milliken S, Marriott D, et al. Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course. J Med Microbiol. 2007;56:699-701. (Pubitemid 46717499)
31. Uchino M, Ogawa Y, Kawai M, et al. Ocular complications in a child with acute graft-versus-host disease following cord blood stem cell transplantation: therapeutic challenges. Acta Ophthalmol Scand. 2006;84: 545-548. (Pubitemid 44102854)
32. Yoshida A, Kawano Y, Kato K, et al. Apoptosis in perforated cornea of a patient with graft-versus-host disease. Can J Ophthalmol. 2006;41: 472-475. (Pubitemid 44298961)
33. Auw-Haedrich C, Potsch C, Bohringer D, et al. Histological and immunohistochemical characterisation of conjunctival graft vs host disease following haematopoietic stem cell transplantation. Graefes Arch Clin Exp Ophthalmol. 2007;245:1001-1007. (Pubitemid 46979539)
34. Crippa F, Corey L, Chuang EL, et al. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32:214-219. (Pubitemid 32524790)
35. Fahnehjelm KT, Tornquist AL, Olsson M, et al. Visual outcome and cataract development after allogeneic stem-cell transplantation in children. Acta Ophthalmol Scand. 2007;85:724-733. (Pubitemid 47616788)
36. Fahnehjelm KT, Tornquist AL, Winiarski J. Dry-eye syndrome after allogeneic stem-cell transplantation in children. Acta Ophthalmol Scand. 2008;86:253-258. (Pubitemid 351785096)
37. Kamoi M, Ogawa Y, Dogru M, et al. Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res. 2007;32:837-842. (Pubitemid 350034782)
38. Kerty E, Vigander K, Flage T, et al. Ocular findings in allogeneic stem cell transplantation without total body irradiation. Ophthalmology. 1999;106: 1334-1338. (Pubitemid 30191481)
39. Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2006;38:223-227. (Pubitemid 44102950)
40. Marena C, Zecca M, Carenini ML, et al. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Infect Control Hosp Epidemiol. 2001;22:510-517. (Pubitemid 33031711)
41. Ogawa Y, Okamoto S, Wakui M, et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol. 1999;83:1125-1130. (Pubitemid 29469114)
42. Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31:579-583. (Pubitemid 36546837)
43. Robinson MR, Lee SS, Rubin BI, et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant. 2004;33:1031-1035.
44. Takahide K, Parker PM, Wu M, et al. Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007;13:1016-1021. (Pubitemid 47215558)
45. Jabs DA, Wingard J, Green WR, et al. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol. 1989;107:1343-1348. (Pubitemid 19229080)
46. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, et al. Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology. 2009; 116:1624-1629.
47. van Dorp S, Meijer E, van de Donk NW, et al. Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced. Neth J Med. 2007; 65:178-184. (Pubitemid 47177040)
48. Maloney DG, Molina AJ, Sahebi F, et al. Allografting with non-myeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood. 2003;102:3447-3454. (Pubitemid 37314788)
49. Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood. 2003;102:756-762. (Pubitemid 36842003)
50. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295-304.
51. Arai S, Klingemann HG. Hematopoietic stem cell transplantation: bone marrow vs. mobilized peripheral blood. Arch Med Res. 2003;34:545-553. (Pubitemid 38088008)